Akari Therapeutics, Plc (NASDAQ:AKTX) Short Interest Update
Akari Therapeutics, Plc (NASDAQ:AKTX – Get Free Report) saw a significant decline in short interest in the month of February. As of February 15th, there was short interest totalling 77,700 shares, a ...
argenx (NASDAQ:ARGX) Receives “Outperform” Rating from William Blair
(NASDAQ:ARGX – Get Free Report)‘s stock had its “outperform” rating reissued by analysts at William Blair in a report released on Friday,RTT News reports. William Blair also issued estimates for ...